Zobrazeno 1 - 10
of 247
pro vyhledávání: '"Susan J. Knox"'
Autor:
Susan J. Knox, Priya Jayachandran, Christine A. Keeling, Kathryn J. Stevens, Navjot Sandhu, Stacy Leanne Stamps-DeAnda, Rada Savic, Lei Shura, Mark K. Buyyounouski, Kevin Grimes
Publikováno v:
Translational Oncology, Vol 12, Iss 11, Pp 1525-1531 (2019)
In preclinical studies, selenite had single agent activity and radiosensitized tumors in vivo. Here we report results from a Phase 1 trial in 15 patients with metastatic cancer treated with selenite (5.5 to 49.5 mg) orally as a single dose 2 hours be
Externí odkaz:
https://doaj.org/article/08b01bdd9c0e418f94f6a4dfc4e92a99
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Glioblastoma is an aggressive and inevitably recurrent primary intra-axial brain tumor with a dismal prognosis. The current mainstay of treatment involves maximally safe surgical resection followed by radiotherapy over a 6-week period with concomitan
Externí odkaz:
https://doaj.org/article/313115a120a844ef831e13fd574c20b7
Autor:
Quaovi H Sodji, Paulina M Gutkin, Susan M Swetter, Sunil A Reddy, Susan M Hiniker, Susan J Knox
Publikováno v:
Melanoma Management, Vol 7, Iss 1 (2020)
Aim: We previously reported a prospective trial evaluating the safety and efficacy of combining ipilimumab and radiation therapy in patients with metastatic melanoma. Herein, we provide a long-term update on patients with complete response (CR) or pa
Externí odkaz:
https://doaj.org/article/b0a08ad854ea4a80888fbd8122d6b6ff
Autor:
Aizea Morales-Kastresana, Thomas A. Musich, Joshua A. Welsh, William Telford, Thorsten Demberg, James C. S. Wood, Marty Bigos, Carley D. Ross, Aliaksander Kachynski, Alan Dean, Edward J. Felton, Jonathan Van Dyke, John Tigges, Vasilis Toxavidis, David R. Parks, W. Roy Overton, Aparna H. Kesarwala, Gordon J. Freeman, Ariel Rosner, Stephen P. Perfetto, Lise Pasquet, Masaki Terabe, Katherine McKinnon, Veena Kapoor, Jane B. Trepel, Anu Puri, Hisataka Kobayashi, Bryant Yung, Xiaoyuan Chen, Peter Guion, Peter Choyke, Susan J. Knox, Ionita Ghiran, Marjorie Robert-Guroff, Jay A. Berzofsky, Jennifer C. Jones
Publikováno v:
Journal of Extracellular Vesicles, Vol 8, Iss 1 (2019)
Biological nanoparticles, including viruses and extracellular vesicles (EVs), are of interest to many fields of medicine as biomarkers and mediators of or treatments for disease. However, exosomes and small viruses fall below the detection limits of
Externí odkaz:
https://doaj.org/article/35b24a5cb7a045568c0b5774e0dc12d8
Autor:
Michelle M. Kim, Hemant Parmar, Yue Cao, Priyanka Pramanik, Matthew Schipper, James Hayman, Larry Junck, Aaron Mammoser, Jason Heth, Corey A. Carter, Arnold Oronsky, Susan J. Knox, Scott Caroen, Bryan Oronsky, Jan Scicinski, Theodore S. Lawrence, Christopher D. Lao
Publikováno v:
Translational Oncology, Vol 9, Iss 2, Pp 108-113 (2016)
BACKGROUND: Kim et al. report two patients with melanoma metastases to the brain that responded to treatment with RRx-001 and whole brain radiotherapy (WBRT) without neurologic or systemic toxicity in the context of a phase I/II clinical trial. RRx-0
Externí odkaz:
https://doaj.org/article/ac84a71275804d769d56c8fbc96deefe
Autor:
Susan J. Knox, Donna M. Peehl, Xuejun Li, Sarah R. Young, Stephen W. Reese, Rosalie Nolley, Hongjuan Zhao, Junqiang Tian
PDF file, 66KB, Serum biochemistry panel.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a2c6e7cbe7c64b7ec8af46c2559d81c
https://doi.org/10.1158/1078-0432.22451397.v1
https://doi.org/10.1158/1078-0432.22451397.v1
Autor:
Christopher A. Barker, Katherine S. Panageas, Holden T. Maecker, Priyanka B. Subrahmanyam, Jedd D. Wolchok, Paul B. Chapman, Margaret K. Callahan, Alexander N. Shoushtari, Parisa Momtaz, Ralph Venhaus, Aileen Ryan, Toni Ricciardi, Paul Schwarzenberger, Mary Macri, Kristen Aufiero Ramirez, Danielle McCabe, Kenya Vado, Sunil K. Reddy, Darragh Halpenny, Phillip Wong, Vikram Mavinkurve, Yuval Elhanati, Debra A. Goldman, Susan J. Knox, Michael A. Postow
TEAE (grade {greater than or equal to}2 events or grade 1 events occurring in {greater than or equal to}2 patients)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2527cd3dedbe0fd4b14c3bd8fa5cbaaa
https://doi.org/10.1158/1078-0432.22476692.v1
https://doi.org/10.1158/1078-0432.22476692.v1
Autor:
Christopher A. Barker, Katherine S. Panageas, Holden T. Maecker, Priyanka B. Subrahmanyam, Jedd D. Wolchok, Paul B. Chapman, Margaret K. Callahan, Alexander N. Shoushtari, Parisa Momtaz, Ralph Venhaus, Aileen Ryan, Toni Ricciardi, Paul Schwarzenberger, Mary Macri, Kristen Aufiero Ramirez, Danielle McCabe, Kenya Vado, Sunil K. Reddy, Darragh Halpenny, Phillip Wong, Vikram Mavinkurve, Yuval Elhanati, Debra A. Goldman, Susan J. Knox, Michael A. Postow
Time from prior treatment to start of treatment within this protocol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12b927245209896f51adadd25522b2cb
https://doi.org/10.1158/1078-0432.22476701.v1
https://doi.org/10.1158/1078-0432.22476701.v1
Autor:
Christopher A. Barker, Katherine S. Panageas, Holden T. Maecker, Priyanka B. Subrahmanyam, Jedd D. Wolchok, Paul B. Chapman, Margaret K. Callahan, Alexander N. Shoushtari, Parisa Momtaz, Ralph Venhaus, Aileen Ryan, Toni Ricciardi, Paul Schwarzenberger, Mary Macri, Kristen Aufiero Ramirez, Danielle McCabe, Kenya Vado, Sunil K. Reddy, Darragh Halpenny, Phillip Wong, Vikram Mavinkurve, Yuval Elhanati, Debra A. Goldman, Susan J. Knox, Michael A. Postow
Additional description of correlative immunologic assays
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b73548f2b930487c0bf75cdb08bf0b1
https://doi.org/10.1158/1078-0432.22476704.v1
https://doi.org/10.1158/1078-0432.22476704.v1
Autor:
Christopher A. Barker, Katherine S. Panageas, Holden T. Maecker, Priyanka B. Subrahmanyam, Jedd D. Wolchok, Paul B. Chapman, Margaret K. Callahan, Alexander N. Shoushtari, Parisa Momtaz, Ralph Venhaus, Aileen Ryan, Toni Ricciardi, Paul Schwarzenberger, Mary Macri, Kristen Aufiero Ramirez, Danielle McCabe, Kenya Vado, Sunil K. Reddy, Darragh Halpenny, Phillip Wong, Vikram Mavinkurve, Yuval Elhanati, Debra A. Goldman, Susan J. Knox, Michael A. Postow
Absolute numbers (absolute lymphocyte count * proportion) of designated cell populations at pre-treatment baseline (V1); after the completion of RT/prior to the 3rd dose of immunotherapy (week 6-9, V2); and at the timepoint of first radiographic asse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6460880c4dee4517ba7db2a204562a53
https://doi.org/10.1158/1078-0432.22476710
https://doi.org/10.1158/1078-0432.22476710